Cerity Partners
TECH icon

Cerity Partners’s Bio-Techne TECH Stock Holding History

Cerity Partners’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.65M Buy
136,616
+12,261
+10% +$662K 0.01% 784
2026
Q1 		$6.5M Buy
124,355
+4,399
+4% +$264K 0.01% 893
2025
Q4 		$7.05M Sell
119,956
-26,894
-18% -$1.63M 0.01% 802
2025
Q3 		$8.17M Sell
146,850
-12,790
-8% -$685K 0.01% 661
2025
Q2 		$8.21M Buy
159,640
+26,898
+20% +$1.35M 0.01% 607
2025
Q1 		$7.78M Buy
132,742
+22,259
+20% +$1.51M 0.02% 579
2024
Q4 		$8.76M Sell
110,483
-47,246
-30% -$3.47M 0.02% 531
2024
Q3 		$12.6M Buy
157,729
+54,134
+52% +$4.07M 0.03% 428
2024
Q2 		$7.42M Sell
103,595
-37,598
-27% -$2.77M 0.02% 500
2024
Q1 		$9.94M Buy
141,193
+94,988
+206% +$6.8M 0.03% 461
2023
Q4 		$3.57M Buy
46,205
+41,244
+831% +$2.72M 0.01% 618
2023
Q3 		$338K Sell
4,961
-42,610
-90% -$3.37M ﹤0.01% 1113
2023
Q2 		$3.88M Buy
47,571
+5,945
+14% +$478K 0.02% 556
2023
Q1 		$3.75M Buy
41,626
+1,426
+4% +$110K 0.01% 550
2022
Q4 		$3.33M Sell
40,200
-800
-2% -$63.5K 0.02% 434
2022
Q3 		$2.91M Buy
41,000
+3,292
+9% +$284K 0.04% 320
2022
Q2 		$3.27M Buy
37,708
+1,848
+5% +$173K 0.04% 313
2022
Q1 		$3.88M Buy
35,860
+892
+3% +$92K 0.06% 227
2021
Q4 		$4.52M Buy
34,968
+3,528
+11% +$432K 0.07% 213
2021
Q3 		$3.81M Buy
31,440
+1,932
+7% +$235K 0.08% 184
2021
Q2 		$3.32M Buy
29,508
+160
+0.5% +$16.8K 0.07% 201
2021
Q1 		$2.8M Sell
29,348
-156
-0.5% -$14.2K 0.07% 209
2020
Q4 		$2.34M Sell
29,504
-1,988
-6% -$144K 0.08% 189
2020
Q3 		$1.95M Buy
+31,492
New +$2.05M 0.08% 171
2019
Q2 		– Sell
-35,400
Closed -$1.76M – 581
2019
Q1 		$1.76M Buy
35,400
+1,224
+4% +$55.1K 0.12% 179
2018
Q4 		$1.24M Sell
34,176
-4,172
-11% -$174K 0.08% 201
2018
Q3 		$1.96M Buy
38,348
+3,536
+10% +$157K 0.14% 168
2018
Q2 		$1.29M Buy
+34,812
New +$1.33M 0.1% 209

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Cerity Partners's TECH Position: Q2 2026 in Review

Cerity Partners increased its Bio-Techne (TECH) stake by 9.9% in Q2 2026, buying an estimated $662K and bringing the position to 136,616 shares worth $9.65M. The position accounts for 0.01% of the portfolio, ranked #784.

Cerity Partners first reported a position in TECH in Q2 2018 and has held it in 28 quarters since. The position peaked at $12.6M in Q3 2024. 597 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Cerity Partners held 136,616 shares of Bio-Techne worth $9.65M as of Q2 2026.
  • Cerity Partners bought 12,261 Bio-Techne shares in Q2 2026, an estimated $662K.
  • Bio-Techne made up 0.01% of Cerity Partners's portfolio in Q2 2026, its #784 holding.
  • Cerity Partners first reported a position in Bio-Techne in Q2 2018 and has held it in 28 quarters since.
  • Cerity Partners's Bio-Techne position peaked at $12.6M in Q3 2024.
  • 597 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.